Quest Diagnostics (DGX) Deferred Taxes (2009 - 2026)

Quest Diagnostics has reported Deferred Taxes for 18 years, with the latest figure at -$2.0 million in Q2 2026.

• Quarterly Deferred Taxes fell 300.0% year-over-year to -$2.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $143.0 million (up 150.88% YoY) and the FY2025 annual result came in at $105.0 million, up 707.69% from the prior year.
• Deferred Taxes slipped to -$2.0 million in Q2 2026 per DGX's latest filing, from $48.0 million in the prior quarter.
• Over five years, Deferred Taxes peaked at $110.0 million in Q3 2025 and troughed at -$44.0 million in Q4 2022.
• A 5-year average of $6.4 million and a median of -$3.0 million in 2023 frame the typical range for Deferred Taxes.
• The sharpest annual moves came in 2022 and 2024: Deferred Taxes jumped 3150.0% in 2022, then slumped 350.0% in 2024.
• Over 5 years, Deferred Taxes stood at -$44.0 million in 2022, then soared by 77.27% to -$10.0 million in 2023, then jumped by 440.0% to $34.0 million in 2024, then tumbled by 138.24% to -$13.0 million in 2025, then soared by 84.62% to -$2.0 million in 2026.
• According to Business Quant data, Deferred Taxes over the past three periods registered -$2.0 million, $48.0 million, and -$13.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.